Innovation + Going Global, Highlights of Biopharmaceutical Companies' Q3 Reports

Wallstreetcn
2025.10.28 22:21

As of October 28, over 280 listed pharmaceutical and biotechnology companies, including Hengrui Pharma, HUADONG MEDICINE, WuXi AppTec, and Sanyou Medical, have disclosed their Q3 2025 reports, with many companies delivering impressive "report cards." Several pharmaceutical companies have achieved double growth in revenue and profit through the advancement of their R&D pipelines and the launch of innovative drugs, while breakthroughs in overseas business have injected new momentum into their performance. The industry as a whole is showing a positive development trend of "innovation as the foundation and expanding overseas." (Shanghai Securities Journal)

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.